Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to confirm the safety and effectiveness of the Internal Joint Stabilizer - Elbow.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Internal Joint Stabilizer Group | Experimental | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Internal Joint Stabilizer - Elbow (IJS-E) | Device | Device designed for internal stabilization of the elbow |
|
| Measure | Description | Time Frame |
|---|---|---|
| Broberg Morrey Functional Rating | To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients receive a Broberg Morrey Functinoal Rating of Fair or better. | Eight months (6 months post-explant) |
| Recurrent Dislocations | To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients do not have a recurrent dislocation while using the IJS-E or after removal of the IJS-E. | 8 months (6 month post-explant) |
Not provided
Not provided
Inclusion Criteria:
The subject is >21 years of age.
The subject is considered a candidate for the Internal Joint Stabilizer -Elbow (IJS-E) under one of the following indications:
The subject has sufficient quantity or quality of bone. Specifically there is sufficient trochlea of the distal humerus and of sufficient quality that the axis pin of the IJS-E has a secure hold as judged by the surgeon intra-operatively. Also, the screws placed in the ulna must be judged by the surgeon to have sufficient hold.
The subject or legal guardian has been informed of the nature of the study, agrees to its provisions, and has provided informed written consent.
The subject is willing to be available for the appropriate follow-up for the duration of the study.
Exclusion Criteria:
The subject has one of the following conditions:
The subject has imminent, known issues related to life expectancy.
The subject is unable and/or unwilling to cooperate with study procedures, a rehabilitative program, or required follow-up visits.
The subject has a condition that may interfere with the outcome or impede healing.
The subject, in the opinion of the Clinical Investigator, has an existing condition that indicates he/she is not a good candidate for the study.
The subject is unable or unwilling to give informed consent and/or who has no responsible family member willing to give consent.
The subject is transient and has no fixed address.
The subject is a prisoner.
The subject is <21 years of age, or >21 years of age but skeletally immature.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Ring, MD | Massachusetts General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Internal Joint Stabilizer Group | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) Internal Joint Stabilizer - Elbow (IJS-E): Device designed for internal stabilization of the elbow |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E)
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Internal Joint Stabilizer Group | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) Internal Joint Stabilizer - Elbow (IJS-E): Device designed for internal stabilization of the elbow |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Broberg Morrey Functional Rating | To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients receive a Broberg Morrey Functinoal Rating of Fair or better. | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) who completed the study (have final follow-up data). Excludes patients who were lost to follow-up. | Posted | Count of Participants | Participants | Eight months (6 months post-explant) |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Participants Who Completed the Study | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) who completed the study (have final follow-up data) Internal Joint Stabilizer - Elbow (IJS-E): Device designed for internal stabilization of the elbow |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Inflammation | Infections and infestations | Systematic Assessment | Inflammation was observed at the explant site 10 days after the implantation in one patient. The surrounding tissue was cultured negative for infection, but the subject was treated with antibiotics as a precaution. |
Two patients were lost to follow-up prior to IJS-E implant removal (explant).
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Ana Escagedo | Skeletal Dynamics, LLC | 305-596-7585 | AEscagedo@SkeletalDynamics.com |
Not provided
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Height (in) | Mean | Standard Deviation | inches |
|
| Weight (lbs) | Mean | Standard Deviation | lbs |
|
| Side Dominance | Count of Participants | Participants |
|
| Operative Side | Count of Participants | Participants |
|
| Subluxed or Dislocated | Count of Participants | Participants |
|
|
|
| Primary | Recurrent Dislocations | To confirm that the Internal Joint Stabilizer - Elbow (IJS-E) provides temporary stabilization of the elbow joint and allows functional recovery after trauma or chronic dislocation. The study is deemed a success if the at least 75% of patients do not have a recurrent dislocation while using the IJS-E or after removal of the IJS-E. | Patients implanted with the Internal Joint Stabilizer - Elbow (IJS-E) who completed the study (have final follow-up data). Excludes patients who were lost to follow-up. | Posted | Count of Participants | Participants | 8 months (6 month post-explant) |
|
|
|
| 0 |
| 24 |
| 1 |
| 24 |
|
Not provided
Not provided